Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Harbor Capital Advisors Inc. lowered its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 8.9% in the fourth ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Piper Sandler Companies (NYSE:PIPR – Get Free Report)’s stock price was down 1.4% during trading on Tuesday . The stock traded as low as $293.09 and last traded at $297.24. Approximately 150,516 ...

NEW YORK, January 13, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a managing director to the healthcare investment ...

As of December 23, 2024, the average one-year price target for Piper Sandler Companies is $372.30/share. The forecasts range from a low of $368.65 to a high of $383.25.

In a report released today, Paul Newsome from Piper Sandler assigned a Hold rating to Travelers Companies (TRV – Research Report), with a price ...

Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $5.91 which represents a slight increase of $0.15 or 2.60% from the prior close of $5.76. The stock opened at $5.9 and ...

View Piper Sandler Companies (PIPR) current and estimated P/E ratio data provided by Seeking Alpha.

LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...